Oncolytics Biotech Inc.
USD0.88
-0.05 (-5.13%)
CEO
Jared Kelly
IPO Date
2001-10-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
CA
Open
$0.95
Prev. Close
$0.93
Day Low
$0.88
Day High
$1.00
52W Low
$0.33
52W High
$1.51
Market Cap
$0.09B
Volume
1.55M
| 5,050 |
| $0.96 |
| 13 Feb 2026 | Kelly Jared | director, officer: Chief Executive Officer | P-Purchase | Acquired | 29,500 | $0.84 |
| 13 Feb 2026 | Kelly Jared | director, officer: Chief Executive Officer | P-Purchase | Acquired | 5,600 | $0.84 |
| 13 Feb 2026 | Look Kirk | Chief Financial Officer | P-Purchase | Acquired | 12,000 | $0.84 |
| 13 Feb 2026 | Pisano Wayne | director | P-Purchase | Acquired | 30,000 | $0.84 |
| 13 Feb 2026 | Heineman Thomas Charles | Chief Medical Officer | P-Purchase | Acquired | 12,132 | $0.83 |
| 13 Feb 2026 | Brown Deborah Margaret | director | P-Purchase | Acquired | 25,000 | $0.85 |
| 13 Feb 2026 | Hagerman Allison | VP, Product Development | P-Purchase | Acquired | 10,000 | $0.83 |
| 13 Feb 2026 | Seizinger Bernd R. | director | P-Purchase | Acquired | 60,000 | $0.83 |